Yu X, Wang H, Ma S, Chen W, Sun L, Zou Z. Estimating the global and regional burden of lower respiratory infections attributable to leading pathogens and the protective effectiveness of immunization programs. Int J Infect Dis. 2024 Dec;149:107268. doi: 10.1016/j.ijid.2024.107268. Epub 2024 Oct 15. PMID: 39413960.

Zhao B, Zheng H, Timm J, Song Z, Pei S, Xing R, Guo Y, Ma L, Li F, Li Q, Li Y, Huang L, Teng C, Wang N, Gupta A, Juneja S, Huang F, Zhao Y, Ou X. Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in China. Ann Clin Microbiol Antimicrob. 2024 May 3;23(1):40. doi: 10.1186/s12941-024-00697-0. PMID: 38702782; PMCID: PMC11069242.

Liu J, Zeng Z, Li F, Jiang B, Nie Y, Zhang G, Pang B, Sun L, Hao R. Portable and simultaneous detection of four respiratory pathogens through a microfluidic LAMP and real-time fluorescence assay. Analyst. 2024 Oct 7;149(20):5091-5100. doi: 10.1039/d4an00748d. PMID: 39229701.

Teng C, Li L, Su D, Li H, Zhao B, Xia H, Teng H, Song Y, Zheng Y, Cao X, Zheng H, Zhao Y, Ou X. Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates. Heliyon. 2024 May 24;10(11):e31959. doi: 10.1016/j.heliyon.2024.e31959. PMID: 38868072; PMCID: PMC11167346.

Hu Y, Li T, Liu W, Zhu D, Feng X, Chen Y, Zheng H. Prevalence and antimicrobial susceptibility pattern of Mycobacterium abscessus complex isolates in Chongqing, Southwest China. Heliyon. 2024 Jul 14;10(14):e34546. doi: 10.1016/j.heliyon.2024.e34546. PMID: 39113955; PMCID: PMC11305262.

Hu Y, Yu M, You G, Fan J, Zheng H. Evaluation of MeltPro Assay in Identification of Second-Line Injectable Drug Resistance in Multidrug-Resistant Tuberculosis Isolates. Infect Drug Resist. 2024 May 24;17:2069-2076. doi: 10.2147/IDR.S459142. PMID: 38807773; PMCID: PMC11131950.

Yang X, Jiao W, Zeng X, Yu J, Xiao J, Jiang T, Tang H, Bi J, Chen Y, Li X, Chen W, Chen Y, Shen A, Sun L. Assessment of lower respiratory tract microbiota associated with pulmonary tuberculosis in children. Pediatr Pulmonol. 2024 Dec;59(12):3550-3559. doi: 10.1002/ppul.27253. Epub 2024 Sep 16. PMID: 39282716.

Zheng H, Xiao J, Yang H, Li F, Guo Y, Wang Y, Li D, Chen H, Wang X, Li H, Shen C. Epidemiology of tuberculosis among children in Beijing, China, 2012-2021. Epidemiol Infect. 2024 Mar 13;152:e44. doi: 10.1017/S0950268824000414. PMID: 38477024; PMCID: PMC10964184.

孙玉亭,全舒婷,孙柏旭,等. 基于非靶向脂质组学分析脂蛋白Rv1411c对结核分枝杆菌脂质代谢的影响[J]. 中国防痨杂志,2024,46(5):538-548.

Wang Y, Yu X, Liu F, Tian X, Quan S, Jiao A, Yang X, Zeng X, Jiao W, Qi H, Xu F, Li Q, Liu S, Xu B, Sun L, Shen A. Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia. Emerg Microbes Infect. 2023 Dec;12(1):2202272. doi: 10.1080/22221751.2023.2202272. PMID: 37132354; PMCID: PMC10171136.

Chen C, Liu F, Quan S, Chen L, Shen A, Jiao A, Qi H, Yu G. Microplastics in the Bronchoalveolar Lavage Fluid of Chinese Children: Associations with Age, City Development, and Disease Features. Environ Sci Technol. 2023 Aug 29;57(34):12594-12601. doi: 10.1021/acs.est.3c01771. Epub 2023 Aug 14. PMID: 37578997.

Jiang TT, Sun L, Wang TY, Qi H, Tang H, Wang YC, Han Q, Shi XQ, Bi J, Jiao WW, Shen AD. The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Front Cell Infect Microbiol. 2023 May 12;13:1181402. doi: 10.3389/fcimb.2023.1181402. PMID: 37249975; PMCID: PMC10213390.

Hu Y, Fan J, Zhu D, Liu W, Li F, Li T, Zheng H. Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China. Ann Clin Microbiol Antimicrob. 2023 Feb 28;22(1):19. doi: 10.1186/s12941-023-00568-0. PMID: 36855179; PMCID: PMC9976417.

Xiao J, Li J, Quan S, Wang Y, Jiang G, Wang Y, Huang H, Jiao W, Shen A. Development and preliminary assessment of a CRISPR-Cas12a-based multiplex detection of Mycobacterium tuberculosis complex. Front Bioeng Biotechnol. 2023 Aug 25;11:1233353. doi: 10.3389/fbioe.2023.1233353. PMID: 37711452; PMCID: PMC10497956.

Zhuang Z, Sun L, Song X, Zhu H, Li L, Zhou X, Mi K. Trends and challenges of multi-drug resistance in childhood tuberculosis. Front Cell Infect Microbiol. 2023 Jun 2;13:1183590. doi: 10.3389/fcimb.2023.1183590. PMID: 37333849; PMCID: PMC10275406.

Zhdanova S, Jiao WW, Sinkov V, Khromova P, Solovieva N, Mushkin A, Mokrousov I, Belopolskaya O, Masharsky A, Vyazovaya A, Rychkova L, Kolesnikova L, Zhuravlev V, Shen AD, Ogarkov O. Insight into Population Structure and Drug Resistance of Pediatric Tuberculosis Strains from China and Russia Gained through Whole-Genome Sequencing. Int J Mol Sci. 2023 Jun 18;24(12):10302. doi: 10.3390/ijms241210302. PMID: 37373451; PMCID: PMC10299545.

Sun B, Liu F, Yin Q, Jiang T, Fang M, Duan L, Quan S, Tian X, Shen A, Mi K, Sun L. Exploration of Lipid Metabolism Alterations in Children with Active Tuberculosis Using UHPLC-MS/MS. J Immunol Res. 2023 Feb 9;2023:8111355. doi: 10.1155/2023/8111355. PMID: 36815950; PMCID: PMC9936505.

Zheng H, Yang H, Wang Y, Li F, Xiao J, Guo Y, Chen H, Wang X, Li H, Shen C. Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB. Heliyon. 2023 Dec 3;10(1):e23217. doi: 10.1016/j.heliyon.2023.e23217. PMID: 38148816; PMCID: PMC10750055.

Quan S, Zou T, Duan L, Tian X, Wang Y, Zhu Y, Fang M, Shi Y, Wan C, Sun L, Shen A. Clinical Characteristics of Pulmonary Tuberculosis in Children Tested by Xpert MTB/RIF Ultra. Pediatr Infect Dis J. 2023 May 1;42(5):389-395. doi: 10.1097/INF.0000000000003866. Epub 2023 Feb 20. PMID: 36854100.

Li FN, Zheng ZQ, Chen MS, Chen XH, Tuo L. Ancylobacter mangrovi sp. nov., a novel endophytic bacterium isolated from mangrove plant. Syst Appl Microbiol. 2023 May;46(3):126419. doi: 10.1016/j.syapm.2023.126419. Epub 2023 Apr 1. PMID: 37030242.

Li F, Hao X, Lu Q, Tuo L, Liu S, Zheng H, Sibero MT, Shen C, Sun C. Protaetiibacter mangrovi sp. nov., isolated from mangrove soil. J Antibiot (Tokyo). 2023 Sep;76(9):532-539. doi: 10.1038/s41429-023-00627-w. Epub 2023 May 19. PMID: 37208458.

Zheng H, Wang Y, He W, Li F, Xia H, Xiao J, Ou X, Wang S, Shen C, Zhao Y. Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China. Microb Drug Resist. 2023 Mar;29(3):112-114. doi: 10.1089/mdr.2022.0216. Epub 2023 Jan 10. PMID: 36625859.

Chen H, Zheng H, Cui L, Xiao J, Li F, Wang Y, Guo Y, Chen Y, Yuan Y, Shen C. Performance of two interferon-gamma release assays for tuberculosis infection screening in Kawasaki children before immunosuppressive therapy. Front Pediatr. 2023 May 18;11:1162547. doi: 10.3389/fped.2023.1162547. PMID: 37274816; PMCID: PMC10232946.

Tang H, Chen X, Chen M, Li X, Jiang J, Tuo L, Li F. Phycicoccus sonneraticus sp. nov., a Novel Endophytic Actinobacterium Isolated from the Bark of Sonneratia apetala. Curr Microbiol. 2023 Oct 28;80(12):393. doi: 10.1007/s00284-023-03511-w. PMID: 37897506.

焦伟伟,蒋婷婷,申阿东. 新生儿期结核病的诊治与管理[J]. 解放军医学杂志,2023,48(6):648-652.

李桂莲,方敏,姜靖伟,等. 肺结核患儿胃液样本结核分枝杆菌培养阳性率提高方法的探讨[J]. 中国防痨杂志,2023,45(1):31-37.

于晓冉,王石金,杨雪梅,等. 2019—2021年四川省凉山彝族自治州儿童肺结核报告和诊断的变化分析[J]. 中华预防医学杂志,2023,57(8):1153-1159.

王晓彤,李飞娜,申晨. 肺炎支原体P1黏附蛋白结构与功能及其致病性的研究新进展[J]. 标记免疫分析与临床,2023,30(9):1601-1604.

Li J, Luu LDW, Wang X, Cui X, Huang X, Fu J, Zhu X, Li Z, Wang Y, Tai J. Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia. Emerg Microbes Infect. 2022 Dec;11(1):593-605. doi: 10.1080/22221751.2022.2036582. PMID: 35094669; PMCID: PMC8865114.

Liao Q, Zheng Y, Wang Y, Ye L, Liu X, Jiao W, Liu Y, Zhu Y, Jia J, Sun L, Shen A, Wan C. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study. Int J Infect Dis. 2022 Aug;121:113-119. doi: 10.1016/j.ijid.2022.04.023. Epub 2022 Apr 14. PMID: 35429637.

Sun L, Liu Y, Fang M, Chen Y, Zhu Y, Xia C, Jia J, Quan S, Wang Y, Tian X, Shi Y, Duan L, Shi X, Liao Q, Wan C, Shen A. Use of Xpert MTB/RIF Ultra assay on stool and gastric aspirate samples to diagnose pulmonary tuberculosis in children in a high-tuberculosis-burden but resource-limited area of China. Int J Infect Dis. 2022 Jan;114:236-243. doi: 10.1016/j.ijid.2021.11.012. Epub 2021 Nov 10. PMID: 34774781.

Li F, Xiao J, Yang H, Yao Y, Li J, Zheng H, Guo Q, Wang X, Chen Y, Guo Y, Wang Y, Shen C. Development of a Rapid and Efficient RPA-CRISPR/Cas12a Assay for Mycoplasma pneumoniae Detection. Front Microbiol. 2022 Mar 15;13:858806. doi: 10.3389/fmicb.2022.858806. PMID: 35369478; PMCID: PMC8965353.

Quan S, Jiang T, Jiao W, Zhu Y, Liao Q, Liu Y, Fang M, Shi Y, Duan L, Shi X, Wang Y, Tian X, Wan C, Sun L, Shen A. A Novel Cross-Priming Amplification-Based Assay for Tuberculosis Diagnosis in Children Using Gastric Aspirate. Front Microbiol. 2022 Mar 24;13:819654. doi: 10.3389/fmicb.2022.819654. PMID: 35401442; PMCID: PMC8988679.

Wang Z, Bi J, You D, Tang Y, Liu G, Yu J, Jin Z, Jiang T, Tian X, Qi H, Dong L, Dong L, Zhang Q, Zhao W, Shen A. Improving the efficacy for meropenem therapy requires a high probability of target attainment in critically ill infants and children. Front Pharmacol. 2022 Oct 5;13:961863. doi: 10.3389/fphar.2022.961863. PMID: 36278190; PMCID: PMC9581397.

Tian X, Dong L, Jiang TT, Tang BH, Wang ZM, Wu YE, You DP, Bi J, Qian SY, Qi H, Shen AD. Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial. Front Pharmacol. 2022 Nov 17;13:1021661. doi: 10.3389/fphar.2022.1021661. PMID: 36467038; PMCID: PMC9714324.

Liu SP, Xiao J, Liu YL, Wu YE, Qi H, Wang ZZ, Shen AD, Liu G, Zhao W. Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections. Front Pharmacol. 2022 Nov 18;13:1056148. doi: 10.3389/fphar.2022.1056148. PMID: 36467047; PMCID: PMC9718031.

Zheng H, Wang Y, He W, Li F, Xia H, Zhao B, Wang S, Shen C, Zhao Y. In Vitro Activity of Pretomanid against Nontuberculous Mycobacteria. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0181021. doi: 10.1128/AAC.01810-21. Epub 2021 Nov 1. PMID: 34723628; PMCID: PMC8765262.

Peng X, Liao Q, Fang M, Zhu Y, Shi Y, Quan S, Wang Y, Duan L, Shi X, Liu Y, Wang M, Wei Q, Zhou H, Wang Y, Wu X, Yao Y, Sun L, Shen A, Wan C. Detection of pulmonary tuberculosis in children using the Xpert MTB/RIF Ultra assay on sputum: a multicenter study. Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):235-243. doi: 10.1007/s10096-021-04340-0. Epub 2021 Nov 4. PMID: 34734347.

Jiang T, Wang Y, Jiao W, Song Y, Zhao Q, Wang T, Bi J, Shen A. Recombinase Polymerase Amplification Combined with Real-Time Fluorescent Probe for Mycoplasma pneumoniae Detection. J Clin Med. 2022 Mar 23;11(7):1780. doi: 10.3390/jcm11071780. PMID: 35407388; PMCID: PMC9000086.

王亚翠,吴喜蓉,刘芳,等. 2016年至2019年北京住院儿童肺炎支原体感染流行病学特征和耐药性[J]. 中华实用儿科临床杂志,2022,37(14):1082-1085.

中华医学会结核病学分会儿童结核病专业委员会,中国研究型医院学会结核病学专业委员会,国家呼吸系统疾病临床医学研究中心,等. 儿童结核性脑膜炎诊断专家共识[J]. 中华实用儿科临床杂志,2022,37(7):497-501.

中华医学会结核病学分会儿童结核病专业委员会,中国研究型医院学会结核病学专业委员会,国家呼吸系统疾病临床医学研究中心,等. 儿童肺结核诊断专家共识[J]. 中华实用儿科临床杂志,2022,37(7):490-496.

刘芳,焦伟伟,申阿东. 儿童结核病诊断与治疗面临的问题与思考[J]. 中华实用儿科临床杂志,2022,37(7):486-489.

李飞娜,郑惠文,杨海明,等. 基于SAT技术探讨新冠肺炎疫情下北京地区儿童肺炎支原体感染流行病学特征[J]. 标记免疫分析与临床,2022,29(7):1089-1092,1147.

陈豪,申晨. 重视儿童结核病的鉴别诊断[J]. 结核与肺部疾病杂志,2022,3(5):353-357.

郑惠文,李飞娜,申晨. 儿童耐药结核病诊治研究进展[J]. 结核与肺部疾病杂志,2022,3(5):402-404.

王晓彤,李飞娜,申晨. 水通道蛋5在免疫调控中的研究进展[J]. 标记免疫分析与临床,2022,29(10):1777-1783.